Rare diseases
Investigational molecules
Locations
Via Pian Scairolo 9, 6912
Helsinn Healthcare S.A. supports clinical research in paediatric cancer settings focused on preventing chemotherapy-induced nausea and vomiting during both single-day and multi-day high-emetogenic chemotherapy. The work centers on intravenous antiemetic regimens that combine netupitant and palonosetron, with attention to symptom control across treatment cycles in children and adolescents.
Clinical interest extends to repeated administration, treatment tolerability, and comparison with established antiemetic combinations used in oncology care.
Helsinn Healthcare S.A. runs clinical trials in conditions such as Prophylaxis of nausea and vomiting, among others.
Clinical trials run by this sponsor – those enrolling participants first.
GreeceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
